inflammatories < inflammatory < infliximab

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 204.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000008 (2010)	P. Roll [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H.-P. Tony [Allemagne]	Tocilizumab
000012 (2005)	Norihiro Nishimoto [Japon]	Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan
000029 (2011)	Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon]	Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
000030 (2010)	Katja Perdan-Pirkmajer [Slovénie] ; Sonja Praprotnik [Slovénie] ; Matija Tomši [Slovénie]	A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature
000031 (2005)	Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon]	Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
000039 (2011)	Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]	Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000052 (2009)	Miho Suzuki [Japon] ; Misato Hashizume [Japon] ; Hiroto Yoshida [Japon] ; Masahiko Mihara [Japon]	Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
000053 (2011)	Ryota Sakai [Japon] ; Hayato Nagasawa [Japon] ; Eiko Nishi [Japon] ; Ayumi Okuyama [Japon] ; Hirofumi Takei [Japon] ; Takahiko Kurasawa [Japon] ; Tsuneo Kondo [Japon] ; Koji Nishimura [Japon] ; Yuichiro Shirai [Japon] ; Tatsuya Ito [Japon] ; Hideto Kameda [Japon] ; Tsutomu Takeuchi [Japon] ; Koichi Amano [Japon]	Successful treatment of adult-onset Still’s disease with tocilizumab monotherapy: two case reports and literature review
000060 (2013)	Francesco Caso [Italie] ; Luca Iaccarino [Italie] ; Silvano Bettio [Italie] ; Francesca Ometto [Italie] ; Luisa Costa [Italie] ; Leonardo Punzi [Italie] ; Andrea Doria [Italie]	Refractory pemphigus foliaceus and Behçet’s disease successfully treated with tocilizumab
000077 (2013)	A. Ca As-Ventura [Espagne] ; E. Rodríguez [Espagne] ; M. Andreu [Espagne] ; L. Márquez [Espagne]	Tocilizumab in Amyloidosis-Associated Kidney Disease Secondary to Inflammatory Bowel Diseases
000085 (2011)	Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]	Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000095 (2009)	Paul Emery ; Rhonda Siddall	Tocilizumab — IL‐6 inhibition for the treatment of rheumatoid arthritis
000101 (2012)	K. Krüger [Allemagne]	Medikamentöse Interaktionen in der Rheumatologie
000113 (2005)	Josef S. Smolen [Autriche] ; Kurt Redlich [Autriche] ; Jochen Zwerina [Autriche] ; Daniel Aletaha [Autriche] ; Günter Steiner [Autriche] ; Georg Schett [Autriche]	Pro-inflammatory cytokines in rheumatoid arthritis
000117 (2010)	C. B. Confavreux [France] ; R. D. Chapurlat [France]	Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
000120 (2011)	Rene Thonhofer [Autriche] ; Manuela Hiller [Autriche] ; Horst Just [Autriche] ; Markus Trummer [Autriche] ; Cornelia Siegel [Autriche] ; Christian Dejaco [Autriche]	Treatment of refractory adult-onset still’s disease with tocilizumab: report of two cases and review of the literature
000125 (2012)	Nicolas Rohleder [États-Unis] ; Martin Aringer [Allemagne] ; Matthias Boentert [Allemagne]	Role of interleukin‐6 in stress, sleep, and fatigue
000134 (2013)	F. Behrens [Allemagne] ; M. Köhm [Allemagne]	Personalisierte Medizin bei Zytokin-gerichteten Therapien
000141 (2011)	H. Bastian [Allemagne] ; E. Feist [Allemagne] ; G.-R. Burmester [Allemagne]	Therapiestrategien bei rheumatoider Arthritis
000146 (2010)	G. Horneff [Allemagne]	Juvenile Arthritiden
000148 (2013)	L. Naumann [Allemagne] ; E. Feist [Allemagne] ; G.-R. Burmester [Allemagne]	Antizytokintherapie

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "inflammatory" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "inflammatory" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    inflammatory
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021